Francine Lui

Francine Lui

Company: ProteinQure Inc.

Job title: Director, Drug Discovery and Translational Sciences

Seminars:

A Novel Peptide Drug Conjugate Targeting the Scavenger Receptor Sortilin 1 That Exhibits Potent In Vivo Efficacy in Triple Negative Breast Cancer Tumour Models 9:15 am

Explore the intricacies of peptide design tailored for optimal affinity to a specific antigen, ensuring precise targeting for therapeutic delivery Investigate the mechanism of receptor-mediated internalisation, wherein peptide-bound receptors facilitate the uptake of chemotherapeutic payloads into target cells, enhancing therapeutic efficacy Discover the transformative potential of peptide-conjugated chemotherapeutic agents in unlocking targeted therapies, offering new…Read more

day: Conference Day 2

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.